Tumour necrosis factor β gene polymorphisms in myasthenia gravis

European Journal of Immunogenetics

Volumn 25, Issue 6, 1998, Pages 403-408

  Zelano, G ^a   Lino, M M ^a   Evoli, A ^a   Settesoldi, D ^a   Batocchi, A P ^a   Torrente, I ^b   Tonali, P A ^a,c  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN;

ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; GENOTYPE; HUMAN; IMMUNOGENETICS; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MYASTHENIA GRAVIS; PRIORITY JOURNAL; THYMUS HYPERPLASIA;

ALLELES; FEMALE; GENOTYPE; HISTOCOMPATIBILITY TESTING; HLA-A1 ANTIGEN; HLA-B8 ANTIGEN; HLA-DR3 ANTIGEN; HUMANS; LYMPHOTOXIN-ALPHA; MALE; MYASTHENIA GRAVIS; PHENOTYPE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; THYMOMA; THYMUS HYPERPLASIA;

EID: 0032425557     PISSN: 09607420     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2370.1998.00129.x     Document Type: Article

References (44)

1. Abraham, L.J., Du, D.C., Zahedi, K., Dawkins, R.L. & Whitehead, A.G. (1991) Haplotypic polymorphisms of TNFb gene. Immunogenetics, 33, 50.
2. Badenhoop, K., Schwwarz, G., Schleusener, H., Weetman, A.P., Recks, S., Peters, H., Bottazzo, G.F. & Usadel, K.H. (1992) Tumor Necrosis Factor β Gene Polymorphisms in Graves' Disease. Journal of Clinical Endocrinology and Metabolism, 74, 287.
3. Bettinotti, M.P., Hartung, K., Deicher, H., Messer, G., Keller, E., Weiss, E.H. & Albert, E.D. (1993) Polymorphism of tumor necrosis factor beta gene in systemic lupus erythematous: TNFB-MHC haplotypes. Immunngenetics, 37, 449.
4. Choo, S.Y., Spies, T., Strominger, J.L. & Hansen, J.A. (1988) Polymorphism in the tumor necrosis factor gene: association with HLA-B and DR haplotypes. Human Immunology, 23, 86.
5. Compston, D.A.S., Vincent, A., Newson-Davis, J. & Bactchelor. J.R. (1980) Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain, 103, 579.
6. Cuturi, M.C., Murphy, M., Costa-Giomi, M.P., Weinmann, R., Perussia, B. & Trincheri, G. (1987) Indipendent regulation of tumor necrosis factor and lymphotoxin production by himan peripheral blood lymphocytes. Journal of Experimental Medicine, 165, 1581.
7. Dawkins, R., Christiansen, F.T., Garlepp, P.H., Cluskey, J., Hollingsworth, P.N. & Zilko, P.J. (1983) Disease associations with complotypes, supratypes and haplotypes. Immunological Review, 70, 5.
8. Degli Esposti, M.P., Andreas, A., Christiansen, F., Schalke, B., Albert, E. & Dawkins, R.L. (1992) An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics, 35, 355.
9. Engel, A.G. (1984) Myasthenia gravis and myasthenic syndromes. Annals of Neurology, 16, 519.
10. Fritze, D., Naeim, F., Herrman, C., Smith, G.S. & Walford, R.L. (1974) HLA-A antigens in myasthenia gravis. Lancet, i, 240.
11. Fugger, L., Morling, N., Ryder, L.P., Georgsen, J., Jakobsen, B.K., Svejgard, A., Andersen, V., Oxholm, P., Karup Pedersen, F., Friis, J. & Halberg, P. (1989) NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF α) region in primary biliary cirrhosis and in healthy Danes. Scandinavian Journal of Immunology, 30, 185.
12. Jacob, C.O., Fronek, Z. & Lewis, G.D. (1990) Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: relevance to genetic predisposition to systemic lupus erythematosus. Proceedings of National Academy of Sciences, USA, 87, 1233.
13. Kaakinen, A., Pirskaken, R. & Tiilkanen, A. (1975) LD antigens associated with HLA-A8 and myasthenia gravis. Tissue Antigens, 6, 175.
14. Larrick, J.W. & Wright, S.C. (1990) Cytotoxic mechanism of tumor necrosis factor-α. FASEB Journal, 4, 3215.
15. Levison, A.I. & Wheatley, L.M. (1996) The thimus and the pathogenesis of Myasthenia Gravis. Clinical Immunology and Immunopatology, 78, 1.
16. Medcroft, T., Hitman, G.D., Sachs, S.D., Whichelow, C.E., Radfat, T. & Moore, R.H. (1993) Autoimmune renal disease and tumor necrosis factor β gene polymorphism. Clinical Nephrology, 40, 63.
17. Messer, G., Kick, G., Ranki, A., Koskimies, S., Reunala, T. & Meurer, M. (1994) Polymorphism of the Tumor Necrosis Factor Gene in Patients with Dermatitis herpetiformis. Dermatology, 189, 135.
18. Messer, G., Spengler, U., Jung, M.C., Honold, G., Eisemburg, J., Sholz, S., Albert, E.D., Pape, G.R., Riethmuller, G. & Weiss, E.H. (1991a) Allelic variation in the TNF-beta gene does not explain the low TNF-beta response in patients with prymary biliary cirrohosis. Scandinavian Journal of Immunology, 34, 735.
19. Messer, G., Spengler, U., Jung, M.C., Honold, G., Blomer, K., Pape, G.R., Riethmuller, G. & Weiss, E.H. (1991b) Polymorphic structure of the tumor necrosis factor (TNF) locus. An NcoI polymorphism in the first intron of the human TNFβ correlates with a variant amino acid position in position 26 and a reduced level of TNFβ production. Journal of Experimental Medicine, 173, 209.
20. Moller, E., Hammarstrom, L., Smith, E. & Matell, G. (1976) HLA-A8 and LD-8a in patients with myasthenia gravis. Tissue Antigens, 7, 39.
21. Muller-Hermelink, H.K., Marx, A., Geuder, K. & Kirchner, T.H. (1993) The pathological basis of thymoma-associated myasthenia gravis. Annals of New York Academy of Science, 681, 56.
22. Naeim, F., Keesy, J.C., Herrmann, C., Lindstrom, J., Zeller, E. & Walford, R.L. (1978) Association of HLA-B8-DRw3, and Anti-acetylcoline receptor antibodies in myasthenia gravis. Tissue Antigens, 12, 381.
23. Newsom-Davis, J., Willcox, N. & Calder, L. (1991) Thymus cells in myasthenya gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes. New England Journal of Medicine, 305, 1313.
24. Newsom-Davis, J., Willcox, N. & Schluep, M. (1987) Immunological heterogeneity and cellular mechanisms in myasthenia gravis. Annals of the New York Academy of Science, 505, 12.
25. Paul, N.L. & Ruddle, N.H. (1988) Lymphotoxin. Annual Review of Immunology, 6, 407.
26. Peruccio, D., D'Alfonso, S., Borelli, I., Amoroso, A., Mazzola, G., Marsico, D., Bersanti, M. & Richiardi, P. (1993) Distribution of tumor nrcrosis factor alleles (NcoI RFLP) and their relationship to HLA haplotypes in an Italian population. Human Hereditary, 43, 103.
27. Pirskanen, R. (1976) Genetic associations between myasthenia gravis and the HLA system Journal of Neurology, Neurosurgery and Psychiatry, 39, 23.
28. Pirskanen, R., Carlsson, B., Lefvert, A.K., Matell, G., Olerup, O. & Smith, E. (1991) DR/DQ haplotype determines clinical forms of myasthenia gravis. Journal of Autoimmunity, 4, XVII.
29. Pociot, F., Briant, L., Jongeneet, C.V., Molvig, J., Worsaae, H., Abbal, M., Thomsen, M., Nerup, J. & Cambon-Thomseen, A. (1993) Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin dependent diabetes mellitus, European Journal of Immunology, 23, 224.
30. Pociot, F., Molvig, J., Wogensen, L., Worsaae, H., Dalboge, H., Baek, L. & Nerup, J. (1991) A tumor necrosis factor beta gene polymorphism in relation to monokine secretion and insulin dependent diabetes mellitus. Scandinavian Journal of Immunology, 33, 37.
31. Pujol-Borrel, R., Todd, I., Doshi, M., Bottazo, G.F., Sutton, R., Gray, D., Adolf, G.R. & Feldmann, M. (1987) HLA class II induction in human islet cells by interferon-gamma plus tumor necrosis factor or lymphotoxin. Nature, 326, 304.
32. Schalke, B., Kirkner, T., Marx, A., Schmitt, I., Andreasietz, A., Muller-Hermelink, H.K., Albert, E. & Toyka, K. (1991) The thymic remnant in the pathogenesis of thymoma associated myasthenia gravis. Journal of Autoimmunity, 4, XLII.
33. Schluep, M., Willcox, N. & Vincent, A. (1987) Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study. Annals of Neurology, 22, 212.
34. Schonbeck, S., Chrestel, S. & Hohlfeld, R. (1990) Myasthenia gravis: prototype of the antireceptor autoimmune diseases. International Review of Neurobiology, 32, 175.
35. Schonbeck, S., Padberg, F., Hohlfeld, R. & Wekerle, H. (1992) Transplantation of thymic autoimmune microenvironment to severe combined immunodeficient mice: a new model of myasthenia gravis. Journal of Clinical Investigation, 90, 245.
36. Schonheck, S., Padberg, F., Marx, A., Hohlfeld, R. & Wekerle, H. (1993) Transplantation of Myasthenia gravis thymus to SCID mice. Annals of the New York Academy of Science, 681, 66.
37. Schwartz, B.D. (1992) The major histocompatibility complex and disease susceptibility. In: Cecil Textbook of Medicine (ed. by J.B. Wyngaarden, L.H. Smith & J.R. Bennett), p. 1470. W.B. Saunders, Philadelphia.
38. Spuler, S., Sarropulos, A., Marx, A., Hohlfed, R. & Wekerle, H. (1996) Thymoma-associated Myasthenia Gravis. Transplantation of thymoma and extrathymomal thymic tissue into scid mice. American Journal of Pathology, 148, 1359.
39. Steffen, M., Ottman, O.G. & Moore, M.A.S. (1988) Simultaneous production of tumor necrosis factor-α and lymphotoxin by normal T cells after induction with II-2 and anti-T3. Journal of Immunology, 140, 2621.
40. Sung, S., Jung, L.K.L., Walters, J.A., Chen, W., Wang, C.Y. & Fu, S.M. (1988) Production of tumor necrosis factor/cachetin by human B cell lines and tonsillar B cells. Journal of Experimental Medicine, 168, 1539.
41. Vandevyver, C., Raus, P., Stinissen, P., Philippaers, L., Cassiman, J. & Raus, J. (1994) Polymorphism of the Tumor necrosis facfor beta gene in multiple sclerosis and rheumatoid arthritis. European Journal of Immunogenetics, 21, 377.
42. Vieira, L.M., Caillat-Zucman, S., Gajdos, P., Cohen-Kaminsky, S., Casteur, A. & Bach, J. (1993) Identification by genomic typing of non-DR3 HLA class II genes associated with myastenia gravis. Journal of Neuroimmunology, 47, 115.
43. Webb, C.G. & Chaplin, D.D. (1990) Genetic variability at the human tumor necrosis factor loci. Journal of Immunology, 145, 1278.
44. Wekerle, H. (1993) The thymus in Myastenia Gravis. Annals of the New York Academy of Science, 681, 47.